Page last updated: 2024-11-09

chromomycin a3

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Chromomycin A3: Glycosidic antibiotic from Streptomyces griseus used as a fluorescent stain of DNA and as an antineoplastic agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID138911452
MeSH IDM0021737

Synonyms (3)

Synonym
chromomycin a3
CS-W020869
HY-W040129

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Hoechst 33258 itself was selectively toxic for the MM96E melanoma cell line compared with other cell lines, induced a highly dendritic morphology, increased tyrosinase activity and tyrosinase mRNA but decreased the level of gp75 (TRP-1) mRNA; message for a third pigment gene, Pmel-17, was unchanged."( Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
Danoy, PA; Dong, Y; Dunn, IS; Jacobs, JJ; Kaushal, A; McGregor, K; Michel, J; Sturm, RA; Wong, SS; Zhang, XM, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (254)

TimeframeStudies, This Drug (%)All Drugs %
pre-199070 (27.56)18.7374
1990's71 (27.95)18.2507
2000's70 (27.56)29.6817
2010's35 (13.78)24.3611
2020's8 (3.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (1.48%)5.53%
Reviews4 (1.48%)6.00%
Case Studies3 (1.11%)4.05%
Observational0 (0.00%)0.25%
Other259 (95.93%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]